[Federal Register Volume 82, Number 52 (Monday, March 20, 2017)] [Notices] [Pages 14366-14367] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2017-05417] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-Based Products; Public Workshop; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice of public workshop; correction. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Thursday, December 29, 2016. The document announced a [[Page 14367]] public workshop entitled ``Identification and Characterization of the Infectious Disease Risks of Human Cells, Tissues, and Cellular and Tissue-based Products.'' The document was published with an error in the Web site address to access the transcript of the workshop. This document corrects that error. FOR FURTHER INFORMATION CONTACT: Monica Kapoor, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3111C, Silver Spring, MD 20993, [email protected]; or Staci Revette, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 3109B, Silver Spring, MD 20993, [email protected]. SUPPLEMENTARY INFORMATION: In the Federal Register of Thursday, December 29, 2016, in FR Doc. 2016-31628, on page 96008, the following correction is made: On page 96008, in the second column under the Transcripts caption of section III, Participating in the Public Workshop, the third sentence in the fourth paragraph is corrected to read, ``Please be advised that as soon as a transcript of the public workshop is available, it will be accessible at: http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm525001.htm.'' Dated: March 14, 2017. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2017-05417 Filed 3-17-17; 8:45 am] BILLING CODE 4164-01-P